Literature DB >> 2338624

X-ray crystallographic characterization of two polymorphs of 8-(2-methoxycarbonylamino-6-methylbenzyloxy)-2-methyl-3-(2- propynyl)-imidazo [1,2-a]pyridine.

A Miyamae1, S Koda, S Kitamura, Y Okamoto, Y Morimoto.   

Abstract

Structural characterization of two polymorphs (Forms A and B) of 8-(2-methoxycarbonylamino-6-methylbenzyloxy)-2-methyl-3-(2-p ropynyl)-imidazo [1,2-a]pyridine (1) was accomplished by X-ray crystallographic analysis. Form A crystallized in the monoclinic space group C2/c, with a = 42.936 (14), b = 4.356 (1), c = 21.536 (6) A, beta = 109.92 (4) degrees, z = 8, and dcal = 1.275 g/cm3. Form B crystallized in the monoclinic space group P2(1)/c, with a = 4.367 (1), b = 38.214 (3), c = 11.253 (1) A, beta = 95.47 (2) degrees, z = 4, and dcal = 1.292 g/cm3. Some subtle conformational differences between the polymorphs were observed. Although the Form B crystal has a somewhat more compactly packed structure than Form A, this compactness is thought to be disadvantageous to conformational features and to the crystal structure of Form B. The intramolecular hydrogen bonding force between N(1) and NH(22) atoms of Form B is weaker than that of Form A, and the stacking force between the imidazopyridine rings of Form B may also be weaker than that of Form A. Thus, Form A is considered to be a more stable structure than Form B. In DSC analysis, Form B transformed to Form A. Based on these results, phase transformation from Form B to A occurs during a transient fluid state.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2338624     DOI: 10.1002/jps.2600790302

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  1 in total

Review 1.  Pharmaceutical solids: a strategic approach to regulatory considerations.

Authors:  S Byrn; R Pfeiffer; M Ganey; C Hoiberg; G Poochikian
Journal:  Pharm Res       Date:  1995-07       Impact factor: 4.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.